Atypical femur fractures associated with use of bisphosphonates and denosumab

Ann Oncol. 2015 Apr;26(4):819-820. doi: 10.1093/annonc/mdv014. Epub 2015 Jan 20.

Authors

A Farooki¹, M Fornier², P Boland³

Affiliations

¹ Department of Endocrinology. Electronic address: [email protected].
² Department of Breast Medicine Service.
³ Department of Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, USA.

PMID: 25605743
DOI: 10.1093/annonc/mdv014

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Density Conservation Agents / adverse effects*
Diphosphonates / adverse effects*
Female
Femoral Fractures / diagnostic imaging*
Humans
Male
Radiography

Substances

Bone Density Conservation Agents
Diphosphonates